Phebra and University of Wollongong Enter into Collaboration Agreement

Phebra and the University of Wollongong have entered into a new six-year collaboration agreement. This collaboration aims to further advance promising research and development (R&D) endeavours, including clinical trials, focused on patented and targeted arsenic compounds.

This collaboration not only emphasises the creation of new drugs but also the local production and commercialisation of essential medical solutions. Moreover, this extended collaboration further indicates the progress and potential of the research, with the anticipation of moving the developed drug into human trials.

This extended collaboration underscores Phebra's commitment to addressing critical unmet medical needs and actively pursuing the development, local manufacturing, and commercialisation of essential products.Through its partnership with UOW, Phebra aims to introduce novel pharmaceuticals that cater to significant unmet medical requirements.

The recently developed molecule employs a precision targeting system for the controlled delivery of minute quantities of its active component, arsenic, exclusively to predetermined cancer cells.

This innovative approach aims to minimise the occurrence of unintended side effects in non-target cells, thus broadening the drug's therapeutic applicability to challenging-to-treat cancer types. Favourable results have been observed in the case of acute myeloid leukaemia (AML) and pancreatic cell lines, indicating promising outcomes for the drug.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!